Delighted to have our manuscript up on bioRxiv where we performed in vitro immune profiling of the STEM-PD clinical trial cell therapy product
#Parkinsons#CellTherapy#Immunogenicity
The immunological profile of RC17 hESC-derived dopaminergic neural progenitor cells in vitro: implications for the STEM-PD clinical ... https://t.co/KIX6p42DD9 #biorxiv_neursci
New TYP lab publication led by PhD student @alexlish47 out today in @CellReports! We present a reproducible neuron-astrocyte-microglia tri-culture model to study intercellular interactions in Alzheimer's disease. Read more here: https://t.co/JXD07mvSw0
In this week’s @Nature, we publish a group effort to outline a framework for studies with neural #organoids, #assembloids and transplantation.
More details below 1/n
Read the recent paper providing an update on PSC-derived therapies in clinical trials, authored by Melissa Carpenter, ISSCR Board Member, and Agnete Kirkeby (@Kirkeby_Lab), co-chair of the ISSCR 2024 Program Committee. @novonordisk@reNEW_Global
https://t.co/DnBbfqaDzA
🌟 Huge congratulations to our Outstanding Mentor Award winner Dr Joanne Jones! 🌟
As leading Neurology Clinician Scientist at Cambridge, they’re not only advancing research in neuroinflammatory conditions but also a dedicated mentor who empowers the next generation.
1/2
So excited to share our paper showing how blood neurofilament light levels could help predict proximity to disease onset in #Huntingtons
A mammoth 14 year study!
A spin off from our sleep work, TL:DR summary below…🧵
@PDandHDLab@HDBuzzFeed
https://t.co/SPMbRBnp2u
We're proud to announce Dr. Zanna Voysey as a 2024 HDBuzz Prize winner! She shares a new study that details racial disparities in HD care and research. Addressing this could improve the lives of people living with HD in the here-and-now. #medical#hdsa #… https://t.co/7n8fORZ7ad
potential PhD students, please consider two opportunities at the University of Cambridge clinical school:
https://t.co/RxROCpbLPP
https://t.co/HtZkiloFea
#PhD#Cambridge
Members of the Roger Barker and Jo Jones team attending the annual meeting of the EU funded programme of work looking at brain repair and how we can do this better.
We are recruiting! We are looking for new members (postdocs and/or bioinformaticians) to join our team. Translational projects on neuroinflammation, transposable elements and single cell analysis. Email or DM me for more info! @Lund_Stem
Please RT!
https://t.co/YZiOM2GROs
Roger Barker on Movers and Shakers podcast (@moversand6) - brilliant podcast and brilliant overview of the history of cell therapy for Parkinson's 🧠
@PDandHDLab
https://t.co/nvU26WMZgP
📰 Update: After a positive initial safety evaluation, the STEM-PD clinical trial testing a new investigational stem cell-derived therapy for Parkinson’s disease has advanced to higher dose testing.
Learn more ⤵️
https://t.co/KOo9v6UPKi
@ParmarLab@Kirkeby_Lab@lunduniversity
Useful update from @ParmarLab@PDandHDLab@Kirkeby_Lab@Lund_Stem on the "STEM-PD" study – stem cell-based transplantion for #Parkinsons clinical trial; Low dose cohort all doing well/no side effects; First high dose patient has now been transplanted
https://t.co/RXINN6GTGM
Excited to share our new collaborative review:
"A decade of progress: Achievements and future challenges for regenerative medicine research in the United Kingdom"
@ZoeHewitt12@DrJoBarnes@RobertEOwen@PDandHDLab@UKRMP_PSEC
https://t.co/dswzEw1e4o
Happy World Sleep Day! 🌎 😴 and what a great way to mark it with a whole session dedicated to sleep at #BrainConf2024 with
@zanna_voysey
presenting our HD-sleep work in the ECR session.
Excited to see our work - showing that an epigenetic barrier sets the pace of human neuronal maturation - published @Nature. This is the “opus magnum” of @gabriele_ciceri in the lab @MSKCancerCenter with huge thanks to all the collaborators involved https://t.co/B85RnSjjgJ.
A great collaborative review made possible through @The_MRC@UKRMP_PSEC and Canadian @StemCellNetwork
"Modeling the neuroimmune system in Alzheimer's and Parkinson's diseases"
New review from @yvonnereinwald & colleagues examines the modeling of the neuroimmune system in #Alzheimers & #Parkinsons research; "There is a scarcity of studies on microfluidic chips for AD & PD", which could⬇️the use of disease-irrelevant animal models
https://t.co/2b0vHPw81g